Understanding how drugs interact with physiologically relevant environments is crucial for the future of effective drug design. An important class of potential drugs are central nervous system (CNS) drugs which need to cross the blood brain barrier (BBB) in order function. In the current work, we propose to investigate the solvation structure of drugs which cross the BBB in model environments which mimic the hydrophobic/hydrophilic interface of the BBB.